Dual Role of TLR2 and Myeloid Differentiation Factor 88 in a Mouse Model of Invasive Group B Streptococcal Disease
Open Access
- 15 May 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (10) , 6324-6329
- https://doi.org/10.4049/jimmunol.172.10.6324
Abstract
Toll-like receptors (TLRs) are involved in pathogen recognition by the innate immune system. Different TLRs and the adaptor molecule myeloid differentiation factor 88 (MyD88) were previously shown to mediate in vitro cell activation induced by group B streptococcus (GBS). The present study examined the potential in vivo roles of TLR2 and MyD88 during infection with GBS. When pups were infected locally with a low bacterial dose, none of the TLR2- or MyD88-deficient mice, but all of the wild-type ones, were able to prevent systemic spread of GBS from the initial focus. Bacterial burden was higher in MyD88- than in TLR2-deficient mice, indicating a more profound defect of host defense in the former animals. In contrast, a high bacterial dose induced high level bacteremia in both mutant and wild-type mice. Under these conditions, however, TLR2 or MyD88 deficiency significantly protected mice from lethality, concomitantly with decreased circulating levels of TNF-α and IL-6. Administration of anti-TNF-α Abs to wild-type mice could mimic the effects of TLR2 or MyD88 deficiency and was detrimental in the low dose model, but protective in the high dose model. In conclusion, these data highlight a dual role of TLR2 and MyD88 in the host defense against GBS sepsis and strongly suggest TNF-α as the molecular mediator of bacterial clearance and septic shock.Keywords
This publication has 34 references indexed in Scilit:
- Risk and the Efficacy of Antiinflammatory AgentsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype VStreptococcus agalactiaeProceedings of the National Academy of Sciences, 2002
- Decoding the Patterns of Self and Nonself by the Innate Immune SystemScience, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 DependentThe Journal of Immunology, 2002
- Group B Streptococcal Disease: From Trials and Tribulations to Triumph and TrepidationClinical Infectious Diseases, 2001
- Plasma Levels and Gene Expression of Granulocyte Colony-Stimulating Factor, Tumor Necrosis Factor-α, Interleukin (IL)-1β, IL-6, IL-8, and Soluble Intercellular Adhesion Molecule-1 in Neonatal Early Onset SepsisPediatric Research, 1998
- Predisposing conditions and pathogens in bacteremia in hospitalized childrenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Antibodies to Tumor Necrosis Factor-α: Use as Adjunctive Therapy in Established Group B Streptococcal Disease in Newborn RatsPediatric Research, 1995